Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

The Oncotype DX® recurrence score (RS) predictor has been clinically utilized to appropriately select adjuvant chemotherapy for patients with estrogen receptor (ER)-positive early breast cancer. However, the selection of chemotherapy for patients with intermediate RSs remains controversial. We asse...

Full description

Bibliographic Details
Main Authors: Sung Gwe Ahn, Hak Min Lee, Hak Woo Lee, Seung Ah Lee, Se-Ra Lee, Sun-Hee Leem, Joon Jeong, In-Sun Chu
Format: Article
Language:English
Published: MDPI AG 2013-12-01
Series:International Journal of Molecular Sciences
Subjects:
breast cancer
estrogen receptor
recurrence score
70-gene signature
FOXM1
AURKA
AURKB
BIRC5
Online Access:http://www.mdpi.com/1422-0067/14/12/23685

Internet

http://www.mdpi.com/1422-0067/14/12/23685

Similar Items